Skip to main content

Cancer_Cell_Biology_Research_Program News

VUMC scientists discover key step to kidney fibrosis

Researchers at Vanderbilt University Medical Center for the first time have shown that activation of the epidermal growth factor receptor (EGFR) is essential for the development of kidney fibrosis, tissue scarring following injury that can lead to kidney failure.

Tuesday, November 21st, 2023
Ken Lau named 2023 Stanley Cohen Innovation Fund Awardee

Ken Lau, professor of cell and developmental biology, has been selected to receive a one-year research award from the Stanley Cohen Innovation Fund.

Tuesday, November 7th, 2023
New dean of Basic Sciences aims to take Vanderbilt to the next level in biomedical research, drug discovery
Whether working on dynamic discoveries in the lab, connecting with students and faculty or pursuing his passion for nature photography, acclaimed biomedical researcher John Kuriyan is inspired by his recent move to join Vanderbilt as the new dean of the School of Medicine Basic Sciences and Distinguished University Professor.
Monday, April 3rd, 2023
New screening method could pave the way for future cancer drug discoveries

New screening method could pave the way for future cancer drug discoveries

Tuesday, January 17th, 2023
VUMC researchers upend dogma about vasopressin production

Vanderbilt investigators have discovered that vasopressin, which has long been thought to be produced only in the brain, is also produced in the kidney.

Thursday, January 5th, 2023